Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 20/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 18/20 | 0.60 |
| ▸ | SLC6A2 | P23975 | 12/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3469299 | 1.00 | SLC6A4 (0.60) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL13345108 | 1.00 | SLC6A4 (0.60) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL13345725 | 0.92 | SLC6A4 (0.49) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL13345727 | 0.92 | SLC6A4 (0.49) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL13345106 | 0.92 | SLC6A4 (0.49) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL13345738 | 0.92 | SLC6A4 (0.49) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL3466235 | 0.89 | SLC6A4 (0.67) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL3466233 | 0.89 | SLC6A4 (0.67) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL13345732 | 0.88 | SLC6A4 (0.43) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL13345733 | 0.88 | SLC6A4 (0.43) | SLC6A4SLC6A3SLC6A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010071575-A1 | QUATERNARY PIPERIDINE DERIVATIVES AND USES THEREOF | ASTRAZENECA AB (SE) | 2010-06-24 | — | — | WO | disclosed |
| WO-2010071575-A1 | QUATERNARY PIPERIDINE DERIVATIVES AND USES THEREOF | ASTRAZENECA AB (SE) | 2010-06-24 | — | — | WO | disclosed |